Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Metformin in Parkinson Disease

Trial Phase 2 Recruiting Nov. 20, 2025

Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders

Trial N/A Enrolling by invitation Nov. 20, 2025

A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

Trial Phase 2 Active, not recruiting Nov. 20, 2025

Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease

Trial N/A Recruiting Nov. 20, 2025

Flexible-Dose Trial in Early Parkinson's Disease (PD)

Trial Phase 3 Completed Nov. 20, 2025

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

Trial N/A Recruiting Nov. 20, 2025

Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients

Trial N/A Completed Nov. 20, 2025

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

Trial N/A Recruiting Nov. 19, 2025

tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex

Trial N/A Completed Nov. 19, 2025

Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease

Trial N/A Recruiting Nov. 19, 2025

Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease

Trial N/A Recruiting Nov. 18, 2025

6 Month Follow up Study on the Changes of Postural Stability in Parkinsonian Patients in Response to High Frequency TMS.

Trial N/A Recruiting Nov. 18, 2025

Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder

Trial Phase 2 Completed Nov. 18, 2025

A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease

Trial Phase 2 Completed Nov. 18, 2025

Dual-target, High-dose TMS for PD Patients With FOG

Trial N/A Terminated Nov. 18, 2025

[18F]ACI-15916 PET in α-synucleinopathies

Trial Early Phase 1 Recruiting Nov. 18, 2025

Clozapine-related Immunodeficiency in Parkinsons Disease

Trial Phase 4 Recruiting Nov. 18, 2025

Lithium for Parkinson's: an Extension Trial

Trial Phase 1 Enrolling by invitation Nov. 18, 2025

A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

Trial Phase 1 Completed Nov. 17, 2025

Serious Game for Parkinson's Disease Patients

Trial N/A Completed Nov. 17, 2025